Nano X ImagingÂ (NNOX) Peer Comparison

$0.78

$-0.03 (-3.34%)

As on 01-Sep-2026 14:38EDT

Market cap

$65 Mln

Revenue (TTM)

$15 Mln

P/E Ratio

--

P/B Ratio

0.5

Div. Yield

0 %

Edit

	Nano X ImagingÂ (NNOX)	InMode (INMD)	IceCure Medical (ICCM)
Market cap ($ Mln)	65	855	8
Revenue ($ Mln)	15	375	4
Net Profit ($ Mln)	-76.04	77.51	-16.88
Net Margin (%)	-523.83	20.69	-427.67
RoE (%)	-53.74	11.81	-161.17
Price to Earnings	--	12.27	--
Price-To-Book	0.52	1.36	0.65

Cashflow
Ratios

Cashflow ($ Mln)

	Nano X ImagingÂ (NNOX)	InMode (INMD)	IceCure Medical (ICCM)
Cash From Operating Activities	-40.79	85.26	-14.57
Cash Flow from Investing Activities	29.37	186.03	-0.04
Cash from Financing Activities	21.37	-126.06	15.83
Net Cash Inflow / Outflow	--	--	--

Ratios

Profitability Ratios

	Nano X ImagingÂ (NNOX)	InMode (INMD)	IceCure Medical (ICCM)
ROCE (%)	-43.60	13.33	-181.10
ROE (%)	-53.74	11.81	-161.17
ROA (%)	-41.17	9.85	-64.21
EBIT Margin (%)	-416.29	22.29	-423.69
Net Margin (%)	-523.83	20.69	-427.67
Cash Profit Margin (%)	0.00	0.00	0.00

Growth Ratios

	Nano X ImagingÂ (NNOX)	InMode (INMD)	IceCure Medical (ICCM)
Revenue Growth (%)	25.74	-6.71	41.62
EBIT Growth (%)	-41.56	-37.62	-5.44
Net Profit Growth (%)	-39.49	-56.62	-8.34
EPS Growth (%)	-28.12	-50.09	19.81
Book Value Growth (%)	-34.52	7.29	160.83

Valuation Ratios

	Nano X ImagingÂ (NNOX)	InMode (INMD)	IceCure Medical (ICCM)
Price / Earnings	-2.50	10.03	-0.10
Price / Book Value	1.34	1.38	0.16
Dividend Yield (%)	--	--	--
EV/EBITDA	-2.78	3.60	0.49
Market Cap ($ Cr)	--	--	--

Solvency Ratios

	Nano X ImagingÂ (NNOX)	InMode (INMD)	IceCure Medical (ICCM)
Debt to Equity	0.00	0.00	0.00
Short term debt to equity ratio	0.03	0.00	0.01
Current Ratio	3.64	8.18	2.87
Quick Ratio	3.40	7.28	2.44
Interest Coverage	-520.30	--	-106.52

Operating Efficiency Ratios

	Nano X ImagingÂ (NNOX)	InMode (INMD)	IceCure Medical (ICCM)
Debtors to sales (%)	15.22	20.61	10.46
Asset Turnover	0.08	0.48	0.15
Receivable days	53.55	44.53	39.99
Inventory Days	32.29	341.98	391.29
Payable days	36.05	72.78	177.71
Cash Conversion Cycle	49.78	313.73	253.58

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly